- +65.0% YTD performance
- Highly efficient cash conversion (100% FCF/OCF ratio)
- Trading above its 200-day moving average
Volatile ride for Intellia Therapeutics Inc stock price on Wednesday moving between $14.43 and $16.73
(Updated on Jun 17, 2026)
The Intellia Therapeutics Inc stock price gained 4.47% on the last trading day (Wednesday, 17th Jun 2026), rising from $14.55 to $15.20. During the last trading day the stock fluctuated 15.94% from a day low at $14.43 to a day high of $16.73. The price has fallen in 6 of the last 10 days but is still up by 16.74% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 million more shares were traded than the day before. In total, 12 million shares were bought and sold for approximately $188.74 million.
The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Intellia Therapeutics Inc stock with a 90% probability to be traded between $11.96 and $16.59 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
NTLA Signals & Forecast
Mostly positive signals in the chart today. The Intellia Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $13.46 and $13.40. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 27.30%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Intellia Therapeutics Inc stock
Intellia Therapeutics Inc finds support from accumulated volume at $14.92 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.30 between high and low, or 15.94%. For the last week, the stock has had daily average volatility of 11.52%.
Our recommended stop-loss: $14.31 (-5.84%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 20 days ago.)
Trading Expectations (NTLA) For The Upcoming Trading Day Of Thursday 18th
For the upcoming trading day on Thursday, 18th we expect Intellia Therapeutics Inc to open at $15.45, and during the day (based on 14 day Average True Range), to move between $14.55 and $15.85, which gives a possible trading interval of +/-$1.31 (+/-8.97%) up or down from last closing price. If Intellia Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 8.97% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $15.31 (0.72%) than the support at $14.92 (1.84%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Intellia Therapeutics Inc stock A Buy?
Intellia Therapeutics Inc holds several positive signals and is considered to be a good choice at current levels. We expect the Intellia Therapeutics Inc stock to perform great in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Buy candidate.
Current score:
6.612
Strong Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 18, 2026 - $15.45 ( 1.67%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
NTLA Performance
Trading levels for NTLA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 17.75 | 16.80% |
| R2 | 16.87 | 11.02% |
| R1 | 16.33 | 7.45% |
| Price | 15.20 | |
| S1 | 14.57 | -4.11% |
| S2 | 14.03 | -7.68% |
| S3 | 13.15 | -13.46% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 16.57 | 9.01% |
| R2 | 15.87 | 4.41% |
| R1 | 15.31 | 0.724% |
| Price | 15.20 | |
| S1 | 14.92 | -1.84% |
| S2 | 13.04 | -14.21% |
| S3 | 12.45 | -18.13% |
FAQ
Click here for our free guide on how to buy Intellia Therapeutics Inc Stock.
Buy NTLA